Facts
as of Nov 19, 2026
Advanced single-cell solutions by Atrandi. Discover high-throughput single-cell technologies for genomics, screening, and biological innovation.
It is hiring: 2 open roles, 1 of them posted in the last 30 days.
- Headquarters
- Vilnius, Lithuania
- Founded
- 2016
- Employees
- 51-200estimated range
- Open roles
- 2Alion job postings
As of Nov 19, 2026, Alion lists 2 open roles at Atrandi Biosciences. Atrandi Biosciences is headquartered in Vilnius, Lithuania. It was founded in 2016. The latest round is Series A of $25M, announced in 2025.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring at full speed: most open roles are fresh.
Science & Research is the largest family, 100 of open roles.
1Posted in 30 days50% of open roles are fresh
50%Remote roles1 of 2
1Hiring offices
Can they hire you from United States?by your location
Hires from your country
Companies like this one (Biotechnology, 51-200, United States) name United States in 98% of remote postings
Lithuania1On site
Remote, from elsewhere1Rare
No posting offers visa sponsorship. Remote roles: 1.
Where the openings areshare of open roles · trend
What postings ask forlanguages named in open roles
Degree asked
Master's Degree 100%
1 postings state a degree.
Benefits named in postingsshare of open roles
Retirement plans150%
Relocation assistance150%
Stock options150%
Health insurance150%
Contract type
Full-Time 2
Visa sponsorship in some rolesRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
VilniusBusiest site
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$25MTotal raised
Series ALatest round
1Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
Sources: funding announcements, grant and company registers
Money
Atrandi Biosciences has $25M paid in by investors, lenders and donors.
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Owners & entities
Sources name Lux Capital among the owners or investors of Atrandi Biosciences.
Named investors, no share stated1
Holders and shares as each register or filing states them.
Tech stack
Technologies named in job postings at Atrandi Biosciences over the last 12 months, by layer, with the share of postings for each.
5Technologies in use
2Postings analysed
64/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press